Blockchain

The lifetime of a drug: a blockchain-enabled history

Share this post:

The past couple of years has seen an increasing interest in using blockchain in healthcare. With its ability to capture a lifetime’s history of an asset – be it an individual’s health records or tracking of a drug throughout the supply chain – blockchains have the potential to improve patient outcomes, reduce costs and risk and optimise service delivery.

Whilst healthcare organizations appear to be ahead of the curve in adopting blockchain, life sciences companies are taking a more cautious view.  They face different challenges than many other industries when implementing new processes and technologies due in part to inefficient legacy processes, as well as a cautious attitude to the maturity of the technology. A restrictive regulatory environment that varies by geography is also a major challenge for the life sciences industry.

The IBM Institute for Business Value recently conducted study in collaboration with the Economist Intelligence Unit to understand what executives working included chief financial officers (CFOs), chief technology officers (CTOs) and chief information officers (CIOs). Those participating had to meet specific criteria: they were either working with — or planning to work with — blockchains in the next 12 months, and they needed to be familiar with the blockchain strategies of their organizations.

In our most recent study Team Medicine: How life sciences can win with blockchain, we identified a group of life sciences organizations that are working with and investing in blockchain today, the First Movers. So what potential are they seeing in blockchain that others have yet to understand? Sixty-nine percent of First Movers anticipated seeing the top benefits (in terms of cost, time, risk) in three areas: regulation and compliance, intercompany processes and patient empowerment. They also expect new business models to be built primarily around patient empowerment, end to end serialization, and regulation and compliance.

From a regulation and compliance perspective, blockchain solutions can track compliance and enable smart contract-based checks as a deterrent to non-compliance. They provide an audit trail that tracks drugs within the supply chain, streamlines enforcement, deters bad behaviour and notify parties of any non-compliant events.  In addition, they can track who has shared data and with whom, without revealing the data itself.

To find our more about our blockchain life sciences join Mark Treshock at the HIMSS Conference in Las Vegas. on Wednesday, March 7th from 3:30-4:00pm at the IBM Theater Session # WA12. To see a full listing of the sessions visit our Theaters page https://ibm.biz/BdZF8T.

Learn more about IBM Watson Health presence at HIMSS18 booth #6243: http://ibm.biz/himss18

Alternatively download the paper at ibm.biz/blockchainls

IBM Institute for Business Value, Global Life Sciences & Healthcare Lead

More Blockchain stories

Advance precision medicine with trusted data and AI solutions

Advancing precision medicine to improve diagnoses and treatments relies largely on big data coming from many sources and instruments in volumes that we have never seen before. This exploding growth of data, represented by very large files and many complex data types, pose enormous challenges for researchers that are trying to make sense of all […]

Continue reading

Predictive Modeling for Pharma Marketers: The Personalization Prescription

There’s massive opportunity in the $1,200 billion world of pharmaceutical marketing, and substantive shifts are underway as big data increases scope and narrows focus. Pharma marketers now face the challenge of combining high-level, abstract knowledge with personalized recommendations tailored to patient and health care provider (HCP) needs. Existing sales strategies and current categorization methods are […]

Continue reading

Working together, with you, to transform this industry

IBM, with Watson Health, brings an unprecedented combination of resources and technologies to the healthcare industry. We are creating the path from today to the future to help our clients fully realize potential opportunities and maximize the return of their IT investments. Discover how IBM can help you transform your enterprise. Join us at HIMSS19 […]

Continue reading